These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3701111)

  • 21. Regulation of staphylococcal toxic shock syndrome toxin-1 and total exoprotein production by magnesium ion.
    Mills JT; Dodel AW; Kass EH
    Infect Immun; 1986 Sep; 53(3):663-70. PubMed ID: 3527988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation by improved syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus.
    Wong AC; Downs SA
    J Clin Microbiol; 1989 Nov; 27(11):2482-7. PubMed ID: 2808672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of magnesium ion in the pathogenesis of toxic shock syndrome.
    Kass EH; Parsonnet J; Mills JT
    Trans Assoc Am Physicians; 1987; 100():158-63. PubMed ID: 3137706
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of cotton and rayon/cotton tampons for efficacy of toxic shock syndrome toxin-1 production.
    Tierno PM
    J Infect Dis; 1996 May; 173(5):1289-91. PubMed ID: 8627090
    [No Abstract]   [Full Text] [Related]  

  • 25. Toxic shock syndrome toxin.
    Hanna BA; Tierno PM
    JAMA; 1985 Oct; 254(15):2062. PubMed ID: 4046132
    [No Abstract]   [Full Text] [Related]  

  • 26. Tryptophan auxotypy associated with Staphylococcus aureus that produce toxic-shock-syndrome toxin.
    Chu MC; Melish ME; James JF
    J Infect Dis; 1985 Jun; 151(6):1157-8. PubMed ID: 3998511
    [No Abstract]   [Full Text] [Related]  

  • 27. Pyomyositis and probable toxic shock syndrome caused by a toxin-1 producing strain of Staphylococcus aureus.
    Gahrn-Hansen B; Lundkvist L; Nielsen E
    Eur J Clin Microbiol Infect Dis; 1989 Jan; 8(1):89-90. PubMed ID: 2495959
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of glycerol monolaurate on growth of, and production of toxic shock syndrome toxin-1 and lipase by, Staphylococcus aureus.
    Holland KT; Taylor D; Farrell AM
    J Antimicrob Chemother; 1994 Jan; 33(1):41-55. PubMed ID: 8157573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of producers of enterotoxins and toxic shock syndrome toxin-1 among Staphylococcus aureus strains isolated from atopic dermatitis lesions.
    Akiyama H; Toi Y; Kanzaki H; Tada J; Arata J
    Arch Dermatol Res; 1996 Jun; 288(7):418-20. PubMed ID: 8818194
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of toxic shock syndrome toxin 1 in toxic shock syndrome: overview.
    Schlievert PM
    Rev Infect Dis; 1989; 11 Suppl 1():S107-9. PubMed ID: 2648535
    [No Abstract]   [Full Text] [Related]  

  • 31. [Frequency and microbiological characteristics of toxic shock syndrome toxin-1 producing Staphylococcus aureus from the vaginal fluor].
    Matsushita M
    Kansenshogaku Zasshi; 1986 Mar; 60(3):195-203. PubMed ID: 3095444
    [No Abstract]   [Full Text] [Related]  

  • 32. Magnesium, Staphylococcus aureus and toxic shock syndrome.
    Kass EH
    Magnesium; 1988; 7(5-6):315-9. PubMed ID: 3075248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of the Today contraceptive sponge on growth and toxic shock syndrome toxin-1 production by Staphylococcus aureus.
    Remington KM; Buller RS; Kelly JR
    Obstet Gynecol; 1987 Apr; 69(4):563-9. PubMed ID: 3822297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of tampon wraps on production of toxic shock syndrome toxin 1.
    Robbins RN; Kelly BJ; Hehl GL; Bergdoll MS
    Rev Infect Dis; 1989; 11 Suppl 1():S197-202. PubMed ID: 2928637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics and expression of toxic shock syndrome toxin 1: overview.
    Kreiswirth BN
    Rev Infect Dis; 1989; 11 Suppl 1():S97-100. PubMed ID: 2648542
    [No Abstract]   [Full Text] [Related]  

  • 36. A toroid model for in vitro investigations of toxic shock syndrome toxin-1 production.
    Flood JA; Tripp TJ; Davis CC; Hill DR; Schlievert PM
    J Microbiol Methods; 2004 May; 57(2):283-8. PubMed ID: 15063069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of blood and different media on the production of toxic shock syndrome toxin 1 by Staphylococcus aureus in the tampon sac method.
    Reiser RF; Denzin LK; Bergdoll MS
    J Clin Microbiol; 1988 Dec; 26(12):2672-4. PubMed ID: 3068256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of tampon composition on production of toxic shock syndrome toxin-1 by Staphylococcus aureus in vitro.
    Parsonnet J; Modern PA; Giacobbe KD
    J Infect Dis; 1996 Jan; 173(1):98-103. PubMed ID: 8537689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome. Evidence for additional toxins.
    Garbe PL; Arko RJ; Reingold AL; Graves LM; Hayes PS; Hightower AW; Chandler FW; Broome CV
    JAMA; 1985 May; 253(17):2538-42. PubMed ID: 3981783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of arbekacin on the production of toxic shock syndrome toxin 1 by methicillin-resistant Staphylococcus aureus].
    Miyata A; Araake M; Ogawa H; Hanaki H; Hiramatsu K
    Jpn J Antibiot; 2001 Jul; 54(7):372-81. PubMed ID: 11560056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.